中文名 | 4-{[((叔丁氧基)羰基]氨基} -1H-吡唑-3-羧酸 |
---|---|
英文名 | 4-[(2-methylpropan-2-yl)oxycarbonylamino]-1H-pyrazole-5-carboxylic acid |
英文别名 | 4-tert-butoxycarbonylamino-1H-pyrazole-3-carboxylic acid |
分子式 | C9H13N3O4 |
---|---|
分子量 | 227.21700 |
精确质量 | 227.09100 |
PSA | 107.80000 |
LogP | 1.46850 |
储存条件 | 室温 |
海关编码 | 2933199090 |
---|
~85% 896466-71-0 |
文献:ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 238; 244 ; WO 2007/077435 A1 |
~83% 896466-71-0 |
文献:ASTEX THERAPEUTICS LIMITED Patent: WO2008/1101 A2, 2008 ; Location in patent: Page/Page column 292; 298-299 ; |
~% 896466-71-0 |
文献:ASTEX THERAPEUTICS LIMITED Patent: US2010/55094 A1, 2010 ; |
海关编码 | 2933199090 |
---|---|
中文概述 | 2933199090. 其他结构上有非稠合吡唑环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |